Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    December 2025
  1. MYERS S, Davis ES, Franks JA, Davids JS, et al
    Beyond composite measures of regional vulnerability: Rural-urban colorectal cancer mortality disparities mediated by area-level characteristics.
    Cancer. 2025;131:e70098.
    PubMed     Abstract available


    October 2025
  2. FOLKERTS AD, Janczewski LM, Merkow RP
    Liver-directed therapies for colorectal liver metastases.
    Cancer. 2025;131:e70097.
    PubMed     Abstract available


  3. CORONADO GD, Gautom P, Schneider JL, Edelmann AC, et al
    Multilevel challenges and adaptations to patient navigation programs for colorectal cancer screening and follow-up: Findings from the Accelerating Colorectal Cancer Screening and follow-up through Implementation Science consortium.
    Cancer. 2025;131:e70121.
    PubMed     Abstract available


  4. BUCHLER T, Ambrozova M, Majek O, Dianova T, et al
    Risk of second primary malignancies after adjuvant chemotherapy for colon cancer.
    Cancer. 2025;131:e70116.
    PubMed     Abstract available


  5. KO B, Rojanasopondist P, Grady WM
    Top advances of the year: Noninvasive colorectal cancer screening tests.
    Cancer. 2025;131:e70115.
    PubMed     Abstract available


    September 2025
  6. STEVENS SX, Gyawali B
    CodeBreaK or code blue? Assessing sotorasib's vital signs in metastatic colorectal cancer.
    Cancer. 2025;131:e70056.
    PubMed     Abstract available


    August 2025
  7. TANGKA FKL, Ruiz E, Ibarra R, Hudson SM, et al
    Effectiveness and cost of implementing a patient navigation program to increase colorectal cancer screening in a large federally qualified health center.
    Cancer. 2025;131:e70031.
    PubMed     Abstract available


  8. NIERENGARTEN MB
    Colorectal cancer treatments show promise: Studies find longer progression-free survival and a potential relative reduction in the risk of death with treatment advances.
    Cancer. 2025;131:e70000.
    PubMed    


    July 2025
  9. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus guideline for the management of colorectal cancer with peritoneal metastases.
    Cancer. 2025;131:e35869.
    PubMed     Abstract available


    May 2025
  10. NIERENGARTEN MB
    Potential new standard of care for the first-line treatment of metastatic colorectal cancer: Interim analyses showed significantly better progression-free survival outcomes with the combination regimen versus either chemotherapy alone or nivolumab alo
    Cancer. 2025;131:e35854.
    PubMed    


  11. STIMPSON JP, Liao JM, Morenz AM, Joo JH, et al
    A difference-in-differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening.
    Cancer. 2025;131:e35904.
    PubMed     Abstract available


  12. NIERENGARTEN MB
    Calcium may help to protect against colorectal cancer.
    Cancer. 2025;131:e35827.
    PubMed    


  13. LEE S, Ma C, Caan BJ, Binder AM, et al
    Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer.
    Cancer. 2025;131:e35865.
    PubMed     Abstract available


    April 2025
  14. SUAREZ-RAMOS T, Verganza S, Pagan-Santana Y, Castaneda-Avila MA, et al
    Evaluating the impact of hurricanes and the COVID-19 pandemic on colorectal cancer incidence in Puerto Rico: An interrupted time-series analysis.
    Cancer. 2025;131:e35793.
    PubMed     Abstract available


  15. MACHIDA N, Okumura T, Boku N, Kishimoto J, et al
    A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).
    Cancer. 2025;131:e35807.
    PubMed     Abstract available


  16. CLARKE N, Mooney T, Gallagher P, von Wagner C, et al
    Interventions to increase uptake in a fecal-immunochemical test population-based colorectal cancer screening program: A quasi-experimental study of first-time invitees.
    Cancer. 2025;131:e35760.
    PubMed     Abstract available


    March 2025
  17. RAYCHAUDHURI S, McLaughlin E, Pennell ML, Stefanick M, et al
    The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancer.
    Cancer. 2025;131:e35804.
    PubMed     Abstract available


  18. VOGTMANN E, Yano Y, Zouiouich S, Hua X, et al
    The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States.
    Cancer. 2025;131:e35802.
    PubMed     Abstract available


  19. BROWN JC, Ma C, Shi Q, Saltz LB, et al
    The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance).
    Cancer. 2025;131:e35727.
    PubMed     Abstract available


    February 2025
  20. ESLINGER C, Walden D, McGary A, Emiloju O, et al
    Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
    Cancer. 2025;131:e35756.
    PubMed     Abstract available


  21. BAEKER BISPO J, Jemal A, Islami F
    Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression.
    Cancer. 2025;131:e35724.
    PubMed     Abstract available


    January 2025
  22. PASSMAN JE, Kallan MJ, Roberson JL, Ginzberg SP, et al
    Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.
    Cancer. 2025;131:e35664.
    PubMed     Abstract available


  23. NORIEGA ESQUIVES BS, Moreno PI, Munoz E, Lad TE, et al
    Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial.
    Cancer. 2025;131:e35626.
    PubMed     Abstract available


  24. PANDEY AS, Drogan C, Huo D, Postula K, et al
    Anticipation in families with MLH1-associated Lynch syndrome.
    Cancer. 2025;131:e35589.
    PubMed     Abstract available


    December 2024
  25. NIERENGARTEN MB
    Colorectal cancer screening and prevention: Efforts aim to optimize colonoscopy measures and broaden accessibility to screening in underserved areas.
    Cancer. 2024;130:3945.
    PubMed    


    November 2024
  26. CHAI TS, Rodgers-Fouche LH, Walls JO, Mattia AR, et al
    Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiency.
    Cancer. 2024;130:3888-3893.
    PubMed     Abstract available


  27. DESAI P, Zhou Y, Grenet J, Handelman SK, et al
    Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality.
    Cancer. 2024;130:3879-3887.
    PubMed     Abstract available


    October 2024
  28. COMPTON SLE, Yang S, Madere J, Weltzien EK, et al
    Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer.
    Cancer. 2024 Oct 5. doi: 10.1002/cncr.35599.
    PubMed     Abstract available


  29. SHI KS, Han X, Star J, Zhao J, et al
    Association of health insurance coverage disruptions and breast and colorectal cancer screening.
    Cancer. 2024 Oct 1. doi: 10.1002/cncr.35584.
    PubMed     Abstract available


    September 2024
  30. BHUTIANI N, Peacock O, Uppal A, Hu CY, et al
    The prognostic impact of tumor deposits in colorectal cancer: More than just N1c.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35491.
    PubMed     Abstract available


  31. HE MM, Wang K, Song M
    Reply to "The influence of multivitamin intake on survival patterns in patients with colorectal cancer".
    Cancer. 2024 Sep 15. doi: 10.1002/cncr.35569.
    PubMed    


  32. TANG WZ, Tang Y, Liu TH
    The influence of multivitamin intake on survival patterns in patients with colorectal cancer.
    Cancer. 2024 Sep 14. doi: 10.1002/cncr.35570.
    PubMed    


    August 2024
  33. BEATRICI E, Paciotti M, Nguyen DD, Filipas DK, et al
    Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
    Cancer. 2024;130:2770-2781.
    PubMed     Abstract available


  34. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    PubMed     Abstract available


  35. NIERENGARTEN MB
    Potential new therapy for KRAS-mutated CRC.
    Cancer. 2024;130:2569.
    PubMed    


    July 2024
  36. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    PubMed     Abstract available


    May 2024
  37. MARTINEZ ME, Roesch S, Largaespada V, Castaneda SF, et al
    A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.
    Cancer. 2024 May 25. doi: 10.1002/cncr.35369.
    PubMed     Abstract available


  38. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.
    PubMed    


  39. JANCZEWSKI LM, Browner A, Cotler J, Nelson H, et al
    Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
    Cancer. 2024;130:1702-1710.
    PubMed     Abstract available


    April 2024
  40. SIMONI O, Scarpa M, Castagliuolo I, Stepanyan A, et al
    IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
    Cancer. 2024 Apr 22. doi: 10.1002/cncr.35297.
    PubMed     Abstract available


  41. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    PubMed    


  42. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    PubMed    


    February 2024
  43. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    PubMed     Abstract available


    November 2023
  44. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.